pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4524b |
Genomic Coordinates | chr17: 69099542 - 69099656 |
Description | Homo sapiens miR-4524b stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4524b-3p | ||||||||||||
Sequence | 66| GAGACAGGUUCAUGCUGCUA |85 | ||||||||||||
Evidence | Experimental | ||||||||||||
Experiments | SOLiD | ||||||||||||
SNPs in miRNA |
|
||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SLC29A1 | ||||||||||||||||||||
Synonyms | ENT1 | ||||||||||||||||||||
Description | solute carrier family 29 member 1 (Augustine blood group) | ||||||||||||||||||||
Transcript | NM_001078175 | ||||||||||||||||||||
Other Transcripts | NM_001078177 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SLC29A1 | |||||||||||||||||||||
3'UTR of SLC29A1 (miRNA target sites are highlighted) |
>SLC29A1|NM_001078175|3'UTR 1 CAAAGGATGGACAGAAGGACTGCCTGCCTCCCTCCCTGTCTGCCTCCTGCCCCTTCCTTCTGCCAGGGGTGATCCTGAGT 81 GGTCTGGCGGTTTTTTCTTCTAACTGACTTCTGCTTTCCACGGCGTGTGCTGGGCCCGGATCTCCAGGCCCTGGGGAGGG 161 AGCCTCTGGACGGACAGTGGGGACATTGTGGGTTTGGGGCTCAGAGTCGAGGGACGGGGTGTAGCCTCGGCATTTGCTTG 241 AGTTTCTCCACTCTTGGCTCTGACTGATCCCTGCTTGTGCAGGCCAGTGGAGGCTCTTGGGCTTGGAGAACACGTGTGTC 321 TCTGTGTATGTGTCTGTGTGTCTGCGTCCGTGTCTGTCAGACTGTCTGCCTGTCCTGGGGTGGCTAGGAGCTGGGTCTGA 401 CCGTTGTATGGTTTGACCTGATATACTCCATTCTCCCCTGCGCCTCCTCCTCTGTGTTCTCTCCATGTCCCCCTCCCAAC 481 TCCCCATGCCCAGTTCTTACCCATCATGCACCCTGTACAGTTGCCACGTTACTGCCTTTTTTAAAAATATATTTGACAGA 561 AACCAGGTGCCTTCAGAGGCTCTCTGATTTAAATAAACCTTTCTTGTTTTTTTCTCCATGGCTAAAAAAAAAAAAAAAAA 641 A Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177609. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_2_11
PAR-CLIP data was present in ERX177605. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_2_7
PAR-CLIP data was present in ERX177621. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_3_11
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000393844.1 | 3UTR | CCUCCCUCCCUGUCUGCCUCCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
175 hsa-miR-4524b-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT064889 | ZBTB18 | zinc finger and BTB domain containing 18 | ![]() |
![]() |
2 | 2 | ||||||
MIRT075345 | SF3B3 | splicing factor 3b subunit 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT094174 | PCGF3 | polycomb group ring finger 3 | ![]() |
![]() |
2 | 6 | ||||||
MIRT100109 | ABT1 | activator of basal transcription 1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT102242 | HBP1 | HMG-box transcription factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT124918 | HCCS | holocytochrome c synthase | ![]() |
![]() |
2 | 2 | ||||||
MIRT140195 | CHAC1 | ChaC glutathione specific gamma-glutamylcyclotransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT193891 | HACD3 | 3-hydroxyacyl-CoA dehydratase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT265634 | LDHA | lactate dehydrogenase A | ![]() |
![]() |
2 | 2 | ||||||
MIRT303878 | VAMP8 | vesicle associated membrane protein 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT409756 | CRTAP | cartilage associated protein | ![]() |
![]() |
2 | 4 | ||||||
MIRT441503 | SPG20 | spartin | ![]() |
![]() |
2 | 6 | ||||||
MIRT446882 | ZNF554 | zinc finger protein 554 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447093 | COPRS | coordinator of PRMT5 and differentiation stimulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT449987 | AEN | apoptosis enhancing nuclease | ![]() |
![]() |
2 | 2 | ||||||
MIRT452116 | IFITM1 | interferon induced transmembrane protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452654 | ZNF33A | zinc finger protein 33A | ![]() |
![]() |
2 | 2 | ||||||
MIRT453886 | IFRD1 | interferon related developmental regulator 1 | ![]() |
![]() |
2 | 12 | ||||||
MIRT454143 | FOXRED2 | FAD dependent oxidoreductase domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454501 | SLC29A1 | solute carrier family 29 member 1 (Augustine blood group) | ![]() |
![]() |
2 | 2 | ||||||
MIRT456633 | ARMCX6 | armadillo repeat containing, X-linked 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT457021 | ACADSB | acyl-CoA dehydrogenase, short/branched chain | ![]() |
![]() |
2 | 2 | ||||||
MIRT457055 | NEGR1 | neuronal growth regulator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT457335 | REG4 | regenerating family member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT457421 | CASC5 | kinetochore scaffold 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT457940 | LCE1A | late cornified envelope 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT458486 | RMI1 | RecQ mediated genome instability 1 | ![]() |
![]() |
2 | 10 | ||||||
MIRT458662 | PAGR1 | PAXIP1 associated glutamate rich protein 1 | ![]() |
![]() |
2 | 12 | ||||||
MIRT459784 | IDH3A | isocitrate dehydrogenase 3 (NAD(+)) alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT459864 | SVOP | SV2 related protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT460575 | FEM1A | fem-1 homolog A | ![]() |
![]() |
2 | 2 | ||||||
MIRT460987 | STK17B | serine/threonine kinase 17b | ![]() |
![]() |
2 | 2 | ||||||
MIRT462315 | TMEM109 | transmembrane protein 109 | ![]() |
![]() |
2 | 2 | ||||||
MIRT464407 | URM1 | ubiquitin related modifier 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465148 | TSC22D2 | TSC22 domain family member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466312 | TIMM22 | translocase of inner mitochondrial membrane 22 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466718 | SYNJ2BP | synaptojanin 2 binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT468258 | SFXN4 | sideroflexin 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT469140 | RNF126 | ring finger protein 126 | ![]() |
![]() |
2 | 2 | ||||||
MIRT471783 | NUP153 | nucleoporin 153 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472506 | NACC2 | NACC family member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT474588 | KLF6 | Kruppel like factor 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475049 | JOSD1 | Josephin domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT476900 | FBXO21 | F-box protein 21 | ![]() |
![]() |
2 | 2 | ||||||
MIRT476972 | FAM83G | family with sequence similarity 83 member G | ![]() |
![]() |
2 | 4 | ||||||
MIRT477433 | EMP1 | epithelial membrane protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT480334 | C5orf51 | chromosome 5 open reading frame 51 | ![]() |
![]() |
2 | 10 | ||||||
MIRT481179 | AVL9 | AVL9 cell migration associated | ![]() |
![]() |
2 | 6 | ||||||
MIRT481693 | AR | androgen receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT483280 | HIVEP3 | human immunodeficiency virus type I enhancer binding protein 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT485775 | B4GALT5 | beta-1,4-galactosyltransferase 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487424 | CACNB1 | calcium voltage-gated channel auxiliary subunit beta 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT488002 | RXRB | retinoid X receptor beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT488259 | DNLZ | DNL-type zinc finger | ![]() |
![]() |
2 | 4 | ||||||
MIRT490360 | DPYSL5 | dihydropyrimidinase like 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT491593 | USB1 | U6 snRNA biogenesis phosphodiesterase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT495269 | IGF2BP1 | insulin like growth factor 2 mRNA binding protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT495619 | ZNF736 | zinc finger protein 736 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496167 | ELP3 | elongator acetyltransferase complex subunit 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496250 | GJB2 | gap junction protein beta 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496915 | RTKN | rhotekin | ![]() |
![]() |
2 | 2 | ||||||
MIRT498713 | PGAM5 | PGAM family member 5, mitochondrial serine/threonine protein phosphatase | ![]() |
![]() |
2 | 10 | ||||||
MIRT501106 | SLC5A6 | solute carrier family 5 member 6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT501831 | NCOA3 | nuclear receptor coactivator 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT507142 | GIGYF1 | GRB10 interacting GYF protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT510991 | PER1 | period circadian clock 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT512283 | ARHGDIA | Rho GDP dissociation inhibitor alpha | ![]() |
![]() |
2 | 6 | ||||||
MIRT513152 | CSDC2 | cold shock domain containing C2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT513327 | KCNMB1 | potassium calcium-activated channel subfamily M regulatory beta subunit 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT515090 | FAM120AOS | family with sequence similarity 120A opposite strand | ![]() |
![]() |
2 | 2 | ||||||
MIRT516113 | OARD1 | O-acyl-ADP-ribose deacylase 1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT516657 | PIGP | phosphatidylinositol glycan anchor biosynthesis class P | ![]() |
![]() |
2 | 2 | ||||||
MIRT516892 | PLEKHS1 | pleckstrin homology domain containing S1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT517966 | ZMIZ2 | zinc finger MIZ-type containing 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT519492 | PNPLA3 | patatin like phospholipase domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT519799 | ZNF226 | zinc finger protein 226 | ![]() |
![]() |
2 | 2 | ||||||
MIRT524309 | CTC1 | CST telomere replication complex component 1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT524425 | CNKSR3 | CNKSR family member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT525927 | KIAA0391 | KIAA0391 | ![]() |
![]() |
2 | 2 | ||||||
MIRT528022 | ACOT9 | acyl-CoA thioesterase 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT528227 | METTL8 | methyltransferase like 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT528686 | CEP57L1 | centrosomal protein 57 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT528774 | CD1D | CD1d molecule | ![]() |
![]() |
2 | 2 | ||||||
MIRT529935 | P2RX7 | purinergic receptor P2X 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT530642 | PPIC | peptidylprolyl isomerase C | ![]() |
![]() |
2 | 4 | ||||||
MIRT530683 | CHRNB1 | cholinergic receptor nicotinic beta 1 subunit | ![]() |
![]() |
2 | 4 | ||||||
MIRT531922 | SLC4A1 | solute carrier family 4 member 1 (Diego blood group) | ![]() |
![]() |
2 | 2 | ||||||
MIRT532181 | SEC14L5 | SEC14 like lipid binding 5 | ![]() |
![]() |
2 | 4 | ||||||
MIRT534996 | PRR11 | proline rich 11 | ![]() |
![]() |
2 | 6 | ||||||
MIRT535452 | PDCL | phosducin like | ![]() |
![]() |
2 | 4 | ||||||
MIRT544682 | AP1S1 | adaptor related protein complex 1 sigma 1 subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT553757 | TARBP2 | TARBP2, RISC loading complex RNA binding subunit | ![]() |
![]() |
2 | 4 | ||||||
MIRT560724 | ZNF749 | zinc finger protein 749 | ![]() |
![]() |
2 | 2 | ||||||
MIRT561518 | SPTY2D1 | SPT2 chromatin protein domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT561578 | SLC30A1 | solute carrier family 30 member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT562483 | CHORDC1 | cysteine and histidine rich domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565039 | VAV2 | vav guanine nucleotide exchange factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565348 | TMED4 | transmembrane p24 trafficking protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT567104 | KANSL1 | KAT8 regulatory NSL complex subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT568879 | LY6H | lymphocyte antigen 6 family member H | ![]() |
![]() |
2 | 2 | ||||||
MIRT569141 | NAP1L4 | nucleosome assembly protein 1 like 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569199 | LRRC3C | leucine rich repeat containing 3C | ![]() |
![]() |
2 | 2 | ||||||
MIRT573559 | TMEM120B | transmembrane protein 120B | ![]() |
![]() |
2 | 2 | ||||||
MIRT575931 | Mrrf | mitochondrial ribosome recycling factor | ![]() |
![]() |
2 | 6 | ||||||
MIRT607035 | MRRF | mitochondrial ribosome recycling factor | ![]() |
![]() |
2 | 9 | ||||||
MIRT607194 | SPRY4 | sprouty RTK signaling antagonist 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT609682 | TMEM213 | transmembrane protein 213 | ![]() |
![]() |
2 | 2 | ||||||
MIRT611227 | ZNF274 | zinc finger protein 274 | ![]() |
![]() |
2 | 2 | ||||||
MIRT611370 | PLXDC1 | plexin domain containing 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT611640 | SCRG1 | stimulator of chondrogenesis 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT613011 | GABRB1 | gamma-aminobutyric acid type A receptor beta1 subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT613532 | GTSE1 | G2 and S-phase expressed 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT614459 | REL | REL proto-oncogene, NF-kB subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT616492 | CD300E | CD300e molecule | ![]() |
![]() |
2 | 2 | ||||||
MIRT617288 | GTF2H3 | general transcription factor IIH subunit 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT618356 | CDKL1 | cyclin dependent kinase like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT619529 | ZNF74 | zinc finger protein 74 | ![]() |
![]() |
2 | 2 | ||||||
MIRT619990 | ZSCAN22 | zinc finger and SCAN domain containing 22 | ![]() |
![]() |
2 | 2 | ||||||
MIRT621286 | ATP5E | ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT621482 | GPKOW | G-patch domain and KOW motifs | ![]() |
![]() |
2 | 2 | ||||||
MIRT625456 | RANGAP1 | Ran GTPase activating protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT626757 | NDUFA9 | NADH:ubiquinone oxidoreductase subunit A9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT629138 | CTCFL | CCCTC-binding factor like | ![]() |
![]() |
2 | 2 | ||||||
MIRT630092 | DCAF10 | DDB1 and CUL4 associated factor 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT633501 | RNF14 | ring finger protein 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT633604 | APCDD1 | APC down-regulated 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT633772 | F2 | coagulation factor II, thrombin | ![]() |
![]() |
2 | 2 | ||||||
MIRT635605 | ADAT1 | adenosine deaminase, tRNA specific 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT637422 | EPB41L3 | erythrocyte membrane protein band 4.1 like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT637822 | PLA2G7 | phospholipase A2 group VII | ![]() |
![]() |
2 | 2 | ||||||
MIRT637978 | RRP36 | ribosomal RNA processing 36 | ![]() |
![]() |
2 | 2 | ||||||
MIRT638385 | RABL3 | RAB, member of RAS oncogene family like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT638547 | KIAA1549 | KIAA1549 | ![]() |
![]() |
2 | 2 | ||||||
MIRT642019 | NCKIPSD | NCK interacting protein with SH3 domain | ![]() |
![]() |
2 | 2 | ||||||
MIRT643342 | MICA | MHC class I polypeptide-related sequence A | ![]() |
![]() |
2 | 2 | ||||||
MIRT644281 | LRRC57 | leucine rich repeat containing 57 | ![]() |
![]() |
2 | 2 | ||||||
MIRT646818 | COX19 | COX19, cytochrome c oxidase assembly factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT646839 | TLDC1 | TBC/LysM-associated domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT646976 | CYP2W1 | cytochrome P450 family 2 subfamily W member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT647735 | CXCR2 | C-X-C motif chemokine receptor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT648598 | ZYG11B | zyg-11 family member B, cell cycle regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT649843 | LIPG | lipase G, endothelial type | ![]() |
![]() |
2 | 2 | ||||||
MIRT650031 | VHL | von Hippel-Lindau tumor suppressor | ![]() |
![]() |
2 | 2 | ||||||
MIRT652082 | TSPAN14 | tetraspanin 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT652103 | TRUB2 | TruB pseudouridine synthase family member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT652902 | SYNPO2L | synaptopodin 2 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT653549 | SLC38A7 | solute carrier family 38 member 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT653981 | SEMA6B | semaphorin 6B | ![]() |
![]() |
2 | 2 | ||||||
MIRT654287 | RCAN1 | regulator of calcineurin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT658372 | FAM63B | MINDY lysine 48 deubiquitinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT660321 | BDP1 | B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB | ![]() |
![]() |
2 | 2 | ||||||
MIRT663063 | LRIF1 | ligand dependent nuclear receptor interacting factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT663269 | ATP1A2 | ATPase Na+/K+ transporting subunit alpha 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT664076 | ZNF417 | zinc finger protein 417 | ![]() |
![]() |
2 | 2 | ||||||
MIRT664193 | MYOZ2 | myozenin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT664512 | POLR3K | RNA polymerase III subunit K | ![]() |
![]() |
2 | 2 | ||||||
MIRT667025 | peptide deformylase, mitochondrial | ![]() |
![]() |
2 | 2 | |||||||
MIRT669621 | ACSL6 | acyl-CoA synthetase long chain family member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT670530 | MLLT6 | MLLT6, PHD finger containing | ![]() |
![]() |
2 | 2 | ||||||
MIRT673050 | SGPL1 | sphingosine-1-phosphate lyase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT683339 | ZNF581 | zinc finger protein 581 | ![]() |
![]() |
2 | 2 | ||||||
MIRT689264 | WDR83OS | WD repeat domain 83 opposite strand | ![]() |
![]() |
2 | 2 | ||||||
MIRT690902 | TOP2A | DNA topoisomerase II alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT699196 | SLX4IP | SLX4 interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT702223 | LONRF3 | LON peptidase N-terminal domain and ring finger 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT707053 | TRPV2 | transient receptor potential cation channel subfamily V member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT707080 | MED29 | mediator complex subunit 29 | ![]() |
![]() |
2 | 2 | ||||||
MIRT712347 | NLN | neurolysin | ![]() |
![]() |
2 | 2 | ||||||
MIRT714715 | KIT | KIT proto-oncogene receptor tyrosine kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT715963 | CES4A | carboxylesterase 4A | ![]() |
![]() |
2 | 2 | ||||||
MIRT718224 | DEFB105B | defensin beta 105B | ![]() |
![]() |
2 | 2 | ||||||
MIRT718244 | DEFB105A | defensin beta 105A | ![]() |
![]() |
2 | 2 | ||||||
MIRT721960 | GCK | glucokinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT723098 | SERINC3 | serine incorporator 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT725207 | PTPRT | protein tyrosine phosphatase, receptor type T | ![]() |
![]() |
2 | 2 |